Utah's life sciences community is set to convene for the 2025 Entrepreneur & Investor Life Sciences Summit, an event designed to bridge research, industry, and investment capital. Hosted by BioUtah and the University of Utah's Technology Licensing Office, the summit will feature prominent speakers and a competitive pitch competition targeting medical device, pharmaceutical, and digital health innovations.
Monica DiCenso from J.P. Morgan Private Bank and Earl Bright from Exploramed headline a distinguished speaker lineup, providing critical insights into the current investment landscape for life sciences ventures. The summit will offer entrepreneurs unique opportunities to connect with venture capital principals and learn strategies for attracting investment.
The event's pitch competition will allow emerging life sciences companies to present their innovations before seasoned judges, with winners receiving cash prizes and recognition. This competitive showcase underscores Utah's growing reputation as a dynamic life sciences hub, which currently contributes $22.6 billion to the state's GDP and supports approximately 180,000 jobs.
By facilitating direct interactions between researchers, entrepreneurs, and investors, the summit aims to accelerate the translation of groundbreaking discoveries into marketable technologies. As Bruce Hunter, University of Utah's chief innovation officer, noted, the event represents a critical platform for strengthening the innovation ecosystem and driving economic growth in the life sciences sector.
